Valuation: AstraZeneca PLC

Market Cap 298B 261B 241B 223B 423B 28,301B 430B 2,886B 1,122B 13,959B 1,119B 1,095B 48,327B P/E 2026 *
24x
P/E 2027 * 21.1x
Enterprise Value 317B 278B 257B 238B 451B 30,127B 458B 3,072B 1,195B 14,860B 1,191B 1,165B 51,447B EV / Sales 2026 *
5.02x
EV / Sales 2027 * 4.63x
Free-Float
96.63%
Yield 2026 *
1.74%
Yield 2027 * 1.83%

Last Transcript: AstraZeneca PLC

1 day+1.87%
1 week+1.87%
Current month+1.87%
1 month+4.12%
3 months-3.97%
6 months+0.98%
Current year+4.16%
1 week 13,838
Extreme 13838
14,686
1 month 11,364
Extreme 11364
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,148
Extreme 10148
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%+1.87%+40.58%+42.08% 292B
+2.96%+3.01%+59.87%+173.31% 1,070B
+3.05%+5.23%+72.11%+67.81% 624B
-0.04%+1.20%+35.72%+87.93% 450B
-2.58%-2.07%+27.62%+22.57% 328B
+1.36%+0.17%+29.90%+49.33% 284B
+1.98%+4.08%-25.78%-39.02% 217B
+0.45%+1.65%+25.65%+68.35% 198B
+5.21%+7.93%+21.99%+83.23% 161B
+1.48%-0.04%-4.64%-32.25% 135B
Average +0.96%+1.84%+28.30%+52.33% 375.95B
Weighted average by Cap. +0.42%+2.21%+41.75%+83.83%

Financials

2026 *2027 *
Net sales 63.19B 55.4B 51.09B 47.32B 89.75B 6,001B 91.26B 612B 238B 2,960B 237B 232B 10,247B 66.85B 58.61B 54.05B 50.06B 94.94B 6,348B 96.54B 647B 252B 3,131B 251B 246B 10,840B
Net income 12.45B 10.92B 10.07B 9.32B 17.69B 1,182B 17.98B 121B 46.9B 583B 46.75B 45.73B 2,019B 13.96B 12.24B 11.29B 10.45B 19.83B 1,326B 20.16B 135B 52.58B 654B 52.41B 51.27B 2,264B
Net Debt 19.24B 16.86B 15.55B 14.4B 27.32B 1,827B 27.78B 186B 72.45B 901B 72.21B 70.65B 3,119B 11.71B 10.27B 9.47B 8.77B 16.63B 1,112B 16.91B 113B 44.1B 548B 43.96B 43.01B 1,899B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-07 GBX 14,364.00 +1.87% 1,528,247
26-07-06 GBX 14,100.00 -2.46% 2,008,204
26-07-03 GBX 14,456.00 -0.56% 653,264
26-07-02 GBX 14,538.00 +4.94% 2,810,574
26-07-01 GBX 13,854.00 -1.74% 1,804,499
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
188.31USD
Average target price
217.11USD
Spread / Average Target
+15.29%

Quarterly revenue - Rate of surprise